Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Population Pharmacokinetics of Monalizumab in Patients With Advanced Solid Tumors.
Hwang M, Fan C, Yue MS, Zhou D, Paturel C, Andre P, Cheng LY, Mitchell P, Kourtesis P, Ruscica D, Das M, Morsli N, Ren S, Gibbs M, Phipps A, Song X. Hwang M, et al. Among authors: phipps a. J Clin Pharmacol. 2023 Jul;63(7):817-829. doi: 10.1002/jcph.2220. Epub 2023 Apr 10. J Clin Pharmacol. 2023. PMID: 36852723
The potential and pitfalls of artificial intelligence in clinical pharmacology.
Johnson M, Patel M, Phipps A, van der Schaar M, Boulton D, Gibbs M. Johnson M, et al. Among authors: phipps a. CPT Pharmacometrics Syst Pharmacol. 2023 Mar;12(3):279-284. doi: 10.1002/psp4.12902. Epub 2023 Jan 30. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 36717763 Free PMC article. No abstract available.
Population Pharmacokinetics and Exposure-Response Analysis of Tremelimumab 300 mg Single Dose Combined with Durvalumab 1500 mg Q4W (STRIDE) in Patients with Unresectable Hepatocellular Carcinoma.
Lim K, Abegesah A, Fan C, He JZ, Song X, Chen C, Negro A, Makowsky M, Gupta C, Ren S, Phipps A, Gibbs M, Zhou D. Lim K, et al. Among authors: phipps a. J Clin Pharmacol. 2023 Nov;63(11):1221-1231. doi: 10.1002/jcph.2288. Epub 2023 Jun 22. J Clin Pharmacol. 2023. PMID: 37300457
Population Pharmacokinetics and Exposure-Response Analysis for the CTLA-4 Inhibitor Tremelimumab in Metastatic NSCLC Patients in the Phase III POSEIDON Study.
He JZ, Duval V, Jauslin P, Gonçalves A, Abegesah A, Fan C, Lim K, Song X, Chen C, Shi X, Mann H, Krug L, Ren S, Phipps A, Gibbs M, Zhou D. He JZ, et al. Among authors: phipps a. Clin Pharmacol Ther. 2023 Dec;114(6):1375-1386. doi: 10.1002/cpt.3063. Epub 2023 Oct 17. Clin Pharmacol Ther. 2023. PMID: 37777827
A mechanistic PK/PD model of AZD0171 (anti-LIF) to support Phase II dose selection.
Shahraz A, Penney M, Candido J, Opoku-Ansah G, Neubauer M, Eyles J, Ojo O, Liu N, Luheshi NM, Phipps A, Vishwanathan K. Shahraz A, et al. Among authors: phipps a. CPT Pharmacometrics Syst Pharmacol. 2024 Oct;13(10):1670-1681. doi: 10.1002/psp4.13204. Epub 2024 Jul 23. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 39041713 Free PMC article.
Association between somatic microsatellite instability, hypermutation status, and specific T cell subsets in colorectal cancer tumors.
Thomas CE, Takashima Y, Wesselink E, Ugai T, Steinfelder RS, Buchanan DD, Qu C, Hsu L, Dias Costa A, Gallinger S, Grant RC, Huyghe JR, Thomas SS, Ogino S, Phipps AI, Nowak JA, Peters U. Thomas CE, et al. Among authors: phipps ai. Front Immunol. 2024 Dec 23;15:1505896. doi: 10.3389/fimmu.2024.1505896. eCollection 2024. Front Immunol. 2024. PMID: 39763680 Free PMC article.
400 results